# EDGAR Filing Document

**Accession Number:** 0001737995
**File Stem:** 0001493152-26-002584
**Filing Date:** 2026-1
**Character Count:** 19783
**Document Hash:** 3e2320724f135d36431d99df5841458c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-002584.hdr.sgml**: 20260116

**ACCESSION NUMBER**: 0001493152-26-002584

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20260115

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260116

**DATE AS OF CHANGE**: 20260116

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sharps Technology Inc.
- **CENTRAL INDEX KEY:** 0001737995
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 823751728
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41355
- **FILM NUMBER:** 26539895

**BUSINESS ADDRESS:**
- **STREET 1:** 105 MAXESS ROAD
- **STREET 2:** STE. 124
- **CITY:** MELVILLE
- **STATE:** NY
- **ZIP:** 11747
- **BUSINESS PHONE:** (631) 574 -4436

**MAIL ADDRESS:**
- **STREET 1:** 105 MAXESS ROAD
- **STREET 2:** STE. 124
- **CITY:** MELVILLE
- **STATE:** NY
- **ZIP:** 11747

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

Date of Report (Date of earliest event reported): January 15, 2026

**SHARPS TECHNOLOGY, INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Nevada** | **001-41355** | **82-3751728** |
| (State or other jurisdiction of<br> incorporation or organization) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

**105 Maxess Road, Suite 124, Melville, NY 11747**

(Address of principal executive office) (Zip Code)

**(631) 574-4436**

(Registrants' telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| **Common Stock, par value $0.0001** | **STSS** | **Nasdaq Capital Market** |
| **Common Stock Purchase Warrants** | **STSSW** | **Nasdaq Capital Market** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

Emerging Growth Company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01. Entry Into a Material Definitive Agreement.**

On January 15, 2026, Sharps Technology, Inc. (the "Company") entered into a lock-up agreement (the "Agreement") with Sol Markets, a Cayman Islands exempt company (the "Strategic Advisor"), pursuant to which, for a period of ninety (90) days from the date thereof, the Strategic Advisor has agreed not to offer, sell, contract to sell, hypothecate, pledge or otherwise dispose of any shares of common stock of the Company or securities convertible, exchangeable or exercisable into, shares of common stock of the Company beneficially owned, held or hereafter acquired by the Strategic Advisor.

The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

**Item 8.01 Other Events.**

On January 16, 2026, the Company issued a press release announcing, amongst other things, the company entering into the Agreement with Sol Markets.

The Company's press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

The information furnished under this Item 8.01 and in the accompanying Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in any such filing.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| 10.1 | [Lock-up Agreement, dated January 15, 2026, by and between Sharps Technology, Inc. and SOL Markets.](ex10-1.htm) |
| 99.1 | [Press Release dated January 16, 2026](ex99-1.htm) |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Sharps Technology, Inc.** | **Sharps Technology, Inc.** |
| Dated: January 16, 2026 | By: | */s/ Paul K. Danner* |
|  | Name: | Paul K. Danner |
|  | Title: | Principal Executive Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**LOCK-UP AGREEMENT**

January 15, 2026

Sharps Technology, Inc.

Re: Strategic Advisor Agreement, dated as of August 28, 2025 (the "Advisor Agreement"), between Sharps Technology, Inc. (the "Company") and Sol Markets, a Cayman Islands exempt company (the "Strategic Advisor").

Ladies and Gentlemen:

Defined terms not otherwise defined in this letter agreement (the "<u>Letter Agreement</u>") shall have the meanings set forth in the Advisor Agreement. The Strategic Advisor irrevocably agrees with the Company that, for a period of ninety (90) days from the date hereof (the "<u>Restriction Period</u>"), the Strategic Advisor will not offer, sell, contract to sell, hypothecate, pledge or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by the Strategic Advisor or any affiliate of the Strategic Advisor or any person in privity with the Strategic Advisor or any affiliate of the Strategic Advisor), directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the "<u>Exchange Act</u>"), with respect to, any shares of common stock of the Company or securities convertible, exchangeable or exercisable into, shares of common stock of the Company beneficially owned, held or hereafter acquired by the Strategic Advisor (the "<u>Securities</u>"). Beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act. In order to enforce this covenant, the Company shall impose irrevocable stop-transfer instructions preventing the transfer agent of the Company from effecting any actions in violation of this Letter Agreement.

Notwithstanding the foregoing, and subject to the conditions below, the Strategic Advisor may transfer the Securities provided that (1) the Company receives a signed lock-up letter agreement (in the form of this Letter Agreement) for the balance of the Restriction Period from each donee, trustee, distributee, or transferee, as the case may be, prior to such transfer (2) any such transfer shall not involve a disposition for value, (3) such transfer is not required to be reported with the Securities and Exchange Commission in accordance with the Exchange Act and no report of such transfer shall be made voluntarily, and (4) neither the Strategic Advisor nor any donee, trustee, distributee or transferee, as the case may be, otherwise voluntarily effects any public filing or report regarding such transfers, with respect to transfer:

&nbsp;&nbsp;&nbsp;&nbsp;i) as
 a *bona fide* gift or gifts;

ii) to any immediate family member or to any trust for the direct or indirect benefit of the Strategic Advisor or the immediate family of the undersigned (for purposes of this Letter Agreement, "immediate family" shall mean any relationship by blood, marriage or adoption, not more remote than first cousin);

iii) to any corporation, partnership, limited liability company, or other business entity all of the equity holders of which consist of the Strategic Advisor and/or the immediate family of the Strategic Advisor;

iv) if the Strategic Advisor is a corporation, partnership, limited liability company, trust or other business entity (a) to another corporation, partnership, limited liability company, trust or other business entity that is an affiliate of the Strategic Advisor or (b) in the form of a distribution to limited partners, limited liability company members or stockholders of the Strategic Advisor;

&nbsp;&nbsp;&nbsp;&nbsp;v) if
 the Strategic Advisor is a trust, to the beneficiary of such trust;

vi) by will, other testamentary document or intestate succession to the legal representative, heir, beneficiary or a member of the immediate family of the Strategic Advisor; or

vii) of securities purchased in open market transactions after the Closing Date.

In addition, notwithstanding the foregoing, this Letter Agreement shall not restrict the delivery of shares of common stock to the Strategic Advisor upon (i) exercise any options granted under any employee benefit plan of the Company; provided that any shares of common stock or Securities acquired in connection with any such exercise will be subject to the restrictions set forth in this Letter Agreement, or (ii) the exercise of warrants; provided that such shares of common stock delivered to the Strategic Advisor in connection with such exercise are subject to the restrictions set forth in this Letter Agreement.

Furthermore, the Strategic Advisor may enter into any new plan established in compliance with Rule 10b5-1 of the Exchange Act; provided that (i) such plan may only be established if no public announcement or filing with the Securities and Exchange Commission, or other applicable regulatory authority, is made in connection with the establishment of such plan during the Restriction Period and (ii) no sale of shares of common stock are made pursuant to such plan during the Restriction Period.

The Strategic Advisor acknowledges that the execution, delivery and performance of this Letter Agreement is a material inducement to the Company to complete the transactions contemplated by the Advisor Agreement and the Company shall be entitled to specific performance of the Strategic Advisor's obligations hereunder. The Strategic Advisor hereby represents that the Strategic Advisor has the power and authority to execute, deliver and perform this Letter Agreement, that the Strategic Advisor has received adequate consideration therefor and that the Strategic Advisor will indirectly benefit from the closing of the transactions contemplated by the Advisor Agreement.

This Letter Agreement may not be amended or otherwise modified in any respect without the written consent of each of the Company and the Strategic Advisor. This Letter Agreement shall be construed and enforced in accordance with the laws of the State of New York without regard to the principles of conflict of laws. The Strategic Advisor hereby irrevocably submits to the exclusive jurisdiction of the United States District Court sitting in the Southern District of New York and the courts of the State of New York located in Manhattan, for the purposes of any suit, action or proceeding arising out of or relating to this Letter Agreement, and hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that (i) it is not personally subject to the jurisdiction of such court, (ii) the suit, action or proceeding is brought in an inconvenient forum, or (iii) the venue of the suit, action or proceeding is improper. The Strategic Advisor hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by receiving a copy thereof sent to the Company at the address in effect for notices to it under the Advisor Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. The Strategic Advisor hereby waives any right to a trial by jury. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. The Strategic Advisor agrees and understands that this Letter Agreement does not intend to create any relationship between the Strategic Advisor and any Purchaser and that no Purchaser is entitled to cast any votes on the matters herein contemplated and that no issuance or sale of the Securities is created or intended by virtue of this Letter Agreement.

This Letter Agreement shall be binding on successors and assigns of the Strategic Advisor with respect to the Securities and any such successor or assign shall enter into a similar agreement for the benefit of the Company. This Letter Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

\*\*\* SIGNATURE PAGE FOLLOWS\*\*\*

This Letter Agreement may be executed in two or more counterparts, all of which when taken together may be considered one and the same agreement.

**Sol Markets**

---

| | |
|:---|:---|
| By: | */s/ James Zhang* |
| Name: | James Zhang |
| Title: | Authorized Signatory |

---

Number of shares of common stock

<u>6,321,367</u>

Number of shares of common stock underlying subject to warrants, options, debentures or other convertible securities

By signing below, the Company agrees to enforce the restrictions on transfer set forth in this Letter Agreement.

**Sharps Technology, Inc.**

---

| | |
|:---|:---|
| By: | */s/ Paul Danner* |
| Name: | Paul Danner |
| Title: | CEO |

---

## Exhibit 99.1

**Exhibit 99.1**

**Sharps Technology Strengthens Market Confidence with Advisor Lock-Up Agreement**

NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (NASDAQ: STSS) today announced that it has entered into a 90-day lock-up agreement with SOL Markets (the "Strategic Advisor"), pursuant to which SOL Markets has agreed to restrict sales of its advisory warrants and any underlying shares. The lock-up reflects strong conviction in STSS's execution roadmap and reinforces alignment between the parties. This comes after the company's recent announcement that its Board of Directors approved a share buyback program for up to $100 million.

Under the terms of the agreement, the Strategic Advisor has voluntarily agreed not to sell, transfer, assign, pledge, hedge, or otherwise dispose of any warrants or underlying shares of STSS common stock for a period of 90 days from the date of signing this agreement. The lock-up arrangement applies to all warrants and underlying shares held by SOL Markets that were issued in connection with advisory and strategic support services and is effective as of January 16, 2026. This commitment reinforces the Strategic Advisor's alignment with the objectives of STSS and demonstrates confidence in the strategic roadmap and anticipated growth of the combined initiatives.

"When a long-term partner voluntarily commits to a lock-up, it sends a powerful signal of alignment, conviction, and confidence in the Company's future," said Paul Danner, Executive Chairman of STSS. "We are pleased to have secured this commitment and believe it reflects the strength of our strategy and the opportunities ahead for Sharps."

James Zhang, Strategic Advisor to STSS added, "We are proud to deepen our alignment with STSS through this lock-up agreement. We have not sold any shares or warrants thus far, and formalizing this commitment further reflects our confidence in Sharps' strategy, execution discipline, and near-term catalysts. We believe Sharps is building toward a differentiated market position, and we are fully committed to supporting the Company's next phase of growth."

Through strategic partnerships, including with <u>Coinbase</u>, <u>Crypto.com</u> and <u>Jupiter</u>, in addition to its Solana treasury and upcoming product research and development initiatives, STSS is driving the development of a universal framework for digital identity and authentication.

STSS's management team has been and continues to conduct institutional investor-focused non-deal roadshows to actively engage with the investment community and showcase the company's upcoming initiatives.

**Forward Looking Statements**

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements in this release other than statements of historical fact are forward-looking statements, including statements regarding the Company's execution of its Solana digital asset treasury strategy, the anticipated benefits of its collaboration with Sol Markets, Coinbase, <u>Crypto.com</u> and Jupiter, and the potential opportunities such initiatives may create for retail and institutional audiences. Forward-looking statements are based on current expectations, assumptions, and beliefs, and involve risks and uncertainties that could cause actual results to differ materially.

These risks and uncertainties include, among others: the Company's ability to successfully execute its Solana treasury strategy; volatility in the market price of SOL and other digital assets; changes in the regulatory or legal environment; competitive pressures; and general market, economic, and business conditions. Additional risks are described in the "Risk Factors" section of the Company's filings with the Securities and Exchange Commission (the "SEC"), which are available on the SEC's website at <u>www.sec.gov</u>.

Forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise these statements, whether as a result of new information, future developments, or otherwise, except as required by law.

**About Sharps Technology**

Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features.

The Company has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.

*Contact*<br> <u>ir@sharpstechnology.com</u>